Position in ELVN
as of Jun 30, 2026
· filed Sep 2, 2026
Position Value
$2,639,406
New position
Shares Held
52,008
first reported quarter
Ownership
0.071%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 32%
Shared 0%
None 68%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Allianz Asset Management GmbH holds $783,743,061 across 80 Biotechnology names. ELVN ranks #25 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
380,618 | $237,330,545 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
545,071 | $131,345,757 | |
| 3 | MRNA |
Moderna, Inc.
|
984,497 | $68,944,324 | |
| 4 | EXEL |
Exelixis, Inc.
|
666,268 | $36,251,640 | |
| 5 | INCY |
Incyte Corp
|
229,921 | $26,063,844 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
418,602 | $23,952,406 | |
| 7 | 177,000 | $23,493,210 | |||
| 8 | FTRE |
Fortrea Holdings Inc.
|
1,141,537 | $19,862,743 |
All Filings in ELVN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,639,406 | 52,008 | Shares | Defined | 2026-09-02 | |
| No filing history on record for this holder in this stock. | ||||||